The news is all good this month. Here’s my M-protein level, which is a marker for the total cancer load in my bone marrow:

This is a significant drop, and I’m only through five weeks of an 8+8 chemo round (weekly for 8 weeks, then biweekly for 8 weeks). It’s almost certain to keep dropping over the next 11 weeks. And that’s not all:

The old chemo med compromised my immune system, and by the start of 2018 I was either at or below the danger level regularly. After I stopped that med and started the new one, my neutrophil level immediately jumped to around the 2000 level, which is perfectly healthy. That’s great news.

Considering all this, it’s worth explaining in a single place what’s going through my head these days. As I’ve mentioned, multiple myeloma is incurable. You can control it, but you can’t kill it off. Eventually it wins.

But not anymore. First of all, there are a bunch of new multiple myeloma drugs that hit the market a couple of years ago. The med I’m taking now is one of them. My first round of chemo lasted for about 3½ years, which isn’t bad, and there’s every reason to think the new drug will give me another two years. Then another will add a year or two to that. By the time I’ve worked my way through all the drugs that are likely to help, it’s now almost a dead certainty that a new form of treatment called CAR-T will be out of clinical trials and available to anyone who needs it (and who’s insured for the vast price it costs). There are several versions of CAR-T already available for other forms of cancer, and several that are in clinical trials for multiple myeloma. My current favorite is a Chinese treatment that was recently picked up by Johnson & Johnson for the North American market. The results so far have been pretty spectacular: a large share of patients appear to be in total remission, which is nearly unheard of. The side effects are sometimes painful, but they’re temporary (a few weeks) and doctors now know how to fight them.

Bottom line: Four years ago multiple myeloma was basically a death sentence. There was no telling how long it would take, but five years was average and ten was the outside range for 99 percent of patients. Today, it looks like I’ll end up going through five or ten years of various annoying rounds of chemo, and then stand a good chance of a total cure. I’ll still die eventually, just like everyone, but probably from tripping and falling down the stairs or something.

So that’s the story. Multiple myeloma is no fun, but I now fully expect a high chance of complete recovery. Thank you, medical researchers.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate